We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+5%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.3B
AUM Growth
+$535M
(+1.3%)
Cap. Flow
-$468M
Cap. Flow
% of AUM
-1.16%
Top 10 Holdings %
Top 10 Hldgs %
15.78%
Holding
2,279
New
170
Increased
711
Reduced
1,071
Closed
189
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$178M |
| 2 |
LyondellBasell Industries
LYB
|
+$133M |
| 3 |
AT&T
T
|
+$124M |
| 4 |
Stanley Black & Decker
SWK
|
+$101M |
| 5 |
Pfizer
PFE
|
+$93.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$229M |
| 2 |
Gilead Sciences
GILD
|
+$164M |
| 3 |
Broadcom
AVGO
|
+$149M |
| 4 |
KeyCorp
KEY
|
+$145M |
| 5 |
Darden Restaurants
DRI
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.22% |
| 2 | Technology | 14.47% |
| 3 | Financials | 10.84% |
| 4 | Industrials | 9.01% |
| 5 | Consumer Discretionary | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
Owens Corning
OC
$10.2B
| $3.65M | 0.01% |
27,933
+11,714
| +72% | +$1.28M |
|
777
WD-40
WDFC
$2.56B
| $3.63M | 0.01% |
19,234
-1,163
| -6% | -$220K |
|
778
Sysco
SYY
$37.8B
| $3.61M | 0.01% |
48,645
+1,047
| +2% | +$77.4K |
|
779
Travel + Leisure Co
TNL
$4.02B
| $3.57M | 0.01% |
88,438
+2,887
| +3% | +$111K |
|
780
Haemonetics
HAE
$4.82B
| $3.57M | 0.01% |
41,875
+34,389
| +459% | +$2.91M |
|
781
Fortive
FTV
$16.8B
| $3.56M | 0.01% |
63,100
-29,148
| -32% | -$1.47M |
|
782
Hancock Whitney
HWC
$6.05B
| $3.55M | 0.01% |
92,610
+7,415
| +9% | +$276K |
|
783
Ligand Pharmaceuticals
LGND
$5.47B
| $3.55M | 0.01% |
49,269
-1,959
| -4% | -$147K |
|
|
HI
784
DELISTED
Hillenbrand
HI
| $3.55M | 0.01% |
69,271
-31,585
| -31% | -$1.52M |
|
|
FNA
785
DELISTED
Paragon 28, Inc.
FNA
| $3.55M | 0.01% |
+200,000
| New | +$3.59M |
|
|
BCOV
786
DELISTED
Brightcove, Inc.
BCOV
| $3.5M | 0.01% |
873,718
-44,858
| -5% | -$181K |
|
787
Columbia Banking Systems
COLB
$8.51B
| $3.5M | 0.01% |
172,691
+141,202
| +448% | +$2.98M |
|
788
Devon Energy
DVN
$54B
| $3.5M | 0.01% |
72,435
+46,455
| +179% | +$2.34M |
|
789
Gibraltar Industries
ROCK
$1.34B
| $3.48M | 0.01% |
55,254
+6,686
| +14% | +$362K |
|
|
CPE
790
DELISTED
Callon Petroleum Company
CPE
| $3.48M | 0.01% |
99,104
+60,116
| +154% | +$2.01M |
|
791
Nasdaq
NDAQ
$49.9B
| $3.46M | 0.01% |
69,460
-905
| -1% | -$49K |
|
792
Everest Group
EG
$14.5B
| $3.46M | 0.01% |
10,125
-77
| -0.8% | -$27.8K |
|
793
Criteo S.A.
CRTO
$836M
| $3.44M | 0.01% |
101,933
+41,319
| +68% | +$1.33M |
|
794
Upwork
UPWK
$1.08B
| $3.42M | 0.01% |
366,631
-733,369
| -67% | -$6.64M |
|
795
Commault Systems
CVLT
$6B
| $3.42M | 0.01% |
47,089
+24,521
| +109% | +$1.59M |
|
796
Flex
FLEX
$41.2B
| $3.41M | 0.01% |
163,885
+5,972
| +4% | +$106K |
|
797
VF Corp
VFC
$5.11B
| $3.41M | 0.01% |
178,802
+13,417
| +8% | +$275K |
|
798
Lattice Semiconductor
LSCC
$15.3B
| $3.4M | 0.01% |
35,387
+3,599
| +11% | +$310K |
|
|
HOUS
799
DELISTED
Anywhere Real Estate
HOUS
| $3.39M | 0.01% |
506,962
-454,528
| -47% | -$2.72M |
|
800
Ford
F
$53.5B
| $3.38M | 0.01% |
223,585
-104,753
| -32% | -$1.33M |
|
Similar funds
Federated Hermes's Q2 2023 Portfolio in Review
As of Q2 2023, Federated Hermes held 2,279 positions worth $40.3B, up 1.3% from $39.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2023 filing shows 170 new, 711 increased, 1,071 reduced and 189 closed positions. Its largest new stake was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M. The largest sale was Clorox, an estimated $229M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q2 2023 buy was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M.
- Federated Hermes added most to Amgen in Q2 2023, an estimated $178M increase.
- Federated Hermes's biggest Q2 2023 reduction was Clorox, cutting an estimated $229M.
- Federated Hermes fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $55.4M.
- Federated Hermes's ten largest holdings make up 16% of its $40.3B portfolio in Q2 2023.
- Federated Hermes opened 170 new positions and closed 189 in Q2 2023.
- Federated Hermes's portfolio value rose 1.3% quarter-over-quarter to $40.3B.
Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.